[go: up one dir, main page]

ES460699A1 - Procedimiento de obtencion de las 4-(quinazolinil) n-aralco-il piperidinas. - Google Patents

Procedimiento de obtencion de las 4-(quinazolinil) n-aralco-il piperidinas.

Info

Publication number
ES460699A1
ES460699A1 ES460699A ES460699A ES460699A1 ES 460699 A1 ES460699 A1 ES 460699A1 ES 460699 A ES460699 A ES 460699A ES 460699 A ES460699 A ES 460699A ES 460699 A1 ES460699 A1 ES 460699A1
Authority
ES
Spain
Prior art keywords
quinazolin
piperidines
aralkyl
oxo
specifically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES460699A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Publication of ES460699A1 publication Critical patent/ES460699A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

El presente invento tiene por objeto nuevas quinazolinonas sustituidas al nitrógeno. Tiene más particularmente por objeto unas N-piperidinoquinazolonas. Tiene específicamente por objeto un procedimiento de obtención de los compuestos de fórmula general I **fórmula** en la cual, Ar representa un radical fenilo, un radical tienilo, un radical fenilo sustituido.
ES460699A 1976-07-14 1977-07-13 Procedimiento de obtencion de las 4-(quinazolinil) n-aralco-il piperidinas. Expired ES460699A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB29317/76A GB1583753A (en) 1976-07-14 1976-07-14 Piperidine derivatives processes for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ES460699A1 true ES460699A1 (es) 1978-12-01

Family

ID=10289639

Family Applications (2)

Application Number Title Priority Date Filing Date
ES460699A Expired ES460699A1 (es) 1976-07-14 1977-07-13 Procedimiento de obtencion de las 4-(quinazolinil) n-aralco-il piperidinas.
ES472563A Expired ES472563A1 (es) 1976-07-14 1978-08-14 Procedimiento de obtencion de las 4-(quinazolinil) n-aral- coil piperidinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES472563A Expired ES472563A1 (es) 1976-07-14 1978-08-14 Procedimiento de obtencion de las 4-(quinazolinil) n-aral- coil piperidinas

Country Status (12)

Country Link
US (1) US4166117A (es)
JP (1) JPS5334784A (es)
BE (1) BE856784A (es)
CA (1) CA1103671A (es)
CH (1) CH625518A5 (es)
DE (1) DE2731299A1 (es)
ES (2) ES460699A1 (es)
FR (1) FR2361385A1 (es)
GB (1) GB1583753A (es)
NL (1) NL7707785A (es)
OA (1) OA05707A (es)
SU (1) SU751324A3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3066434D1 (en) * 1979-11-21 1984-03-08 Kyowa Hakko Kogyo Kk Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
US4344945A (en) * 1980-03-10 1982-08-17 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
US4684654A (en) * 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
PH23565A (en) * 1986-09-05 1989-08-25 Sumitomo Chemical Co Novel pyrimidinylpyrimidine derivatives and a plant disease protectant containing them as the active ingredient
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
CA2118117A1 (en) * 1993-02-18 1994-08-19 Shigeki Fujiwara Adenosine uptake inhibitor
JP2959765B2 (ja) * 1997-12-12 1999-10-06 日本たばこ産業株式会社 ３−ピペリジル−４−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
US6258819B1 (en) * 1999-08-05 2001-07-10 Syntex (U.S.A.) Llc Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones
AU2005212092B2 (en) * 2004-02-13 2011-01-20 Msd K.K. Fused-ring 4-oxopyrimidine derivative
TW200836743A (en) * 2007-01-29 2008-09-16 Xenon Pharmaceuticals Inc Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
WO2014102592A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
SI3353164T1 (sl) 2015-09-23 2022-02-28 Janssen Pharmaceutica, N.V. Bi-heteroaril substituiran 1,4-benzodiazepini in njihove uporabe za zdravljenje raka
EP3353177B1 (en) 2015-09-23 2020-06-03 Janssen Pharmaceutica NV Tricyclic heterocycles for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2694711A (en) * 1952-12-02 1954-11-16 American Cyanamid Co Quinazolone antimalarial compounds
US3086910A (en) * 1960-03-09 1963-04-23 Wallace & Tiernan Inc Central nervous system depressants 3-(2'-pyridyl)-4-quinazolones
US3257397A (en) * 1963-07-26 1966-06-21 Rexall Drug Chemical Substituted 2, 3-dihydro-4(1h)-quinazolinones
US4027028A (en) * 1975-11-10 1977-05-31 Science Union Et Cie Arylethers and pharmaceutical compositions

Also Published As

Publication number Publication date
BE856784A (fr) 1978-01-13
CA1103671A (fr) 1981-06-23
ES472563A1 (es) 1979-10-16
FR2361385A1 (fr) 1978-03-10
US4166117A (en) 1979-08-28
GB1583753A (en) 1981-02-04
SU751324A3 (ru) 1980-07-23
NL7707785A (nl) 1978-01-17
DE2731299A1 (de) 1978-01-19
OA05707A (fr) 1981-05-31
FR2361385B1 (es) 1983-10-07
CH625518A5 (es) 1981-09-30
JPS5334784A (en) 1978-03-31

Similar Documents

Publication Publication Date Title
ES460699A1 (es) Procedimiento de obtencion de las 4-(quinazolinil) n-aralco-il piperidinas.
ES375933A1 (es) Un metodo de preparar un compuesto de 2-amino-4-hidroxi-6- hidroximetil-7, 7 - dimetil - 7,8 - dihidropteridinao una forma tautomera de la misma.
ES248431A1 (es) Un método para producir trihaloacetilpiperazinas n-sustituidas
ES432334A1 (es) Procedimiento de obtencion de derivados 1-amido alquil-4- sulfonil-piperazina.
ES399055A1 (es) Procedimiento de preparacion de nuevas acrilamidas deriva- das de piperazinas sustituidas.
ES393159A1 (es) Procedimiento para la obtencion de compuestos heterocicli- cos de la serie piridona.
GB1533529A (en) 4-amino-6,7-dimethoxy-2-(4-(heterocyclo-carbonyl)piperazin-1-yl)quinazolines
ES404601A1 (es) Un procedimiento para la produccion de esteres de penicili-na o sulfoxido de penicilina.
ES327882A1 (es) Procedimiento para la produccion de derivados de la sulfonilurea.
ES465346A1 (es) Procedimiento para preparar imidazoles 4,5-disustituidos.
ES471754A1 (es) Procedimiento para la obtencion de derivados alifaticos de 4-(fenil)-piperidina sustituidos
ES399830A1 (es) Procedimiento para la preparacion de fosfonatos de bencilo.
ES444064A1 (es) Procedimiento de preparacion de nuevos (aroil-2'-et-1'-il)- 1-(acetamido-4"-piperazin-1"-il-metil)-2-bencimidazoles.
ES426553A1 (es) Procedimiento para preparar 2-formilquinoxalina-1.4-diosidoximas.
ES458604A1 (es) Un metodo para preparar 4-(3,5-dimetilbenzoil)-amino-2,3-di-metil-1-fenil-3-pirazolin-5-ona.
ES310666A1 (es) Un metodo para la produccion de una 2-alcoxicarbonil metil1,4,6,7-tetrahidro-11 bh-benzo (a) quinolizina sustituida.
ES285739A1 (es) Un procedimiento para la fabricación de compuestos heterocíclicos
ES364810A2 (es) Un procedimiento para la obtencion de nuevas amino - diha- logeno-feniletilaminas.
ES355907A3 (es) Procedimiento para preparar 3-imino-benzisotiazolinas sus- tituidas en el atomo de nitrogeno.
ES401239A1 (es) Procedimiento para la obtencion de compuestos heterocicli- cos.
ES438050A1 (es) Procedimiento para la produccion de nuevos derivados de pi- razol.
ES449521A1 (es) Un procedimiento para la preparacion de derivados de 1, 4- dihidropiridina.
ES480064A1 (es) Procedimiento de obtencion de 4-2-metil,2-4-clorofenoxi-n-e-tilen-propanoamido benceno sulfonil ureas.
ES325020A1 (es) Procedimiento para la sintesis de compuestos heterociclicos.
ES422351A1 (es) Un procedimiento para la preparacion de un nuevo compuesto aralquilo.